M31.1 Thrombotic microangiopathy

Name of the Condition

• Thrombotic microangiopathy

Summary

Thrombotic microangiopathy is a condition characterized by the formation of blood clots in small blood vessels, leading to reduced blood flow and potential organ damage. It involves the occlusion of microvasculature, often resulting in hemolytic anemia, thrombocytopenia, and organ dysfunction.

Causes

Thrombotic microangiopathy is caused by abnormalities in the regulation of blood clotting and vessel integrity. Triggers include infections, medications, autoimmune disorders, or genetic mutations affecting the complement system or von Willebrand factor cleaving protease (ADAMTS13).

Risk Factors

• Exposure to certain medications (e.g., chemotherapy, immunosuppressants).
• Infections (e.g., Shiga toxin-producing E. coli, HIV).
• Autoimmune conditions (e.g., systemic lupus erythematosus).
• Pregnancy or postpartum states.
• Genetic predispositions (e.g., complement factor mutations).

Symptoms

• Fatigue and weakness.
• Bruising or petechiae (small red/purple spots on skin).
• Jaundice (yellowing of skin/eyes).
• Reduced urine output or dark urine.
• Neurological symptoms (e.g., confusion, seizures).
• Abdominal pain or swelling.

Diagnosis

Diagnosis relies on clinical evaluation of symptoms, blood tests (e.g., anemia, low platelets, elevated LDH), and assessment of organ function (e.g., kidney or liver tests). Imaging or tissue biopsy may be used to confirm microvascular occlusion, and exclusion of other causes is essential.

Treatment Options

• Plasma exchange (plasmapheresis): To remove antibodies or toxins and replace deficient factors.
• Immunosuppressants: For autoimmune-related cases.
• Supportive care: Blood transfusions, dialysis for kidney failure, or blood pressure management.
• Discontinuation of triggers: If medication or infection is identified as a cause.

Prognosis and Follow-Up

Prognosis varies based on the underlying cause and organ involvement. Early treatment improves outcomes, but severe cases may lead to permanent organ damage. Follow-up includes monitoring blood counts, organ function, and long-term complications (e.g., chronic kidney disease).

Complications

• Acute kidney injury or failure.
• Neurological damage (e.g., stroke, seizures).
• Heart or lung involvement.
• Chronic anemia or thrombocytopenia.
• Recurrence of symptoms.

Lifestyle & Prevention

• Avoid known triggers (e.g., specific medications, infections).
• Maintain hydration and manage underlying conditions (e.g., hypertension, diabetes).
• Seek prompt medical care for infections or unexplained symptoms.
• Follow-up with specialists (e.g., nephrology, hematology) as recommended.

When to Seek Professional Help

Seek immediate medical attention for symptoms like severe fatigue, bruising, jaundice, reduced urine output, or neurological changes. Early intervention is critical to prevent organ damage.

Tips for Medical Coders

Document the underlying cause (e.g., infection, medication, autoimmune) when available, as it may impact coding specificity. Ensure clinical notes support the diagnosis and any associated organ involvement (e.g., kidney, neurological) to justify additional codes if applicable.